Compelling benefit of soluble suppression of tumorigenicity-2 in post-myocardial infarction estimation of risk: The time is right for its routine use in the clinic
- Díez, J.
- Bayes-Genis, A.
Aldizkaria:
Journal of the American Heart Association
ISSN: 2047-9980
Argitalpen urtea: 2017
Alea: 6
Zenbakia: 10
Mota: Editoriala